Abbott Laboratories And 3 Other Stocks Have Very High Payout Ratio

(VIANEWS) – Rio Tinto (RIO), Leggett & Platt (LEG), Abbott Laboratories (ABT) are the highest payout ratio stocks on this list.

We have collected information about stocks with the highest payout ratio up to now. The payout ratio in itself isn’t a guarantee of good investment but it’s an indicator of whether dividends are being paid and how the company chooses to issue them.

When researching a potential investment, the dividend payout ratio is a good statistic to know so here are a few stocks with an above 30% percent payout ratio.

1. Rio Tinto (RIO)

89.75% Payout Ratio

Rio Tinto Group engages in exploring, mining, and processing mineral resources worldwide. The company operates through Iron Ore, Aluminium, Copper, and Minerals Segments. It offers aluminum, copper, iron ore, diamonds, gold, borates, titanium dioxide, salt, silver, molybdenum, and lithium. The company also owns and operates open pit and underground mines, refineries, smelters, and concentrator facilities, as well as power stations, research, and service facilities. Rio Tinto Group was founded in 1873 and is headquartered in London, the United Kingdom.

Earnings Per Share

As for profitability, Rio Tinto has a trailing twelve months EPS of $7.64.

PE Ratio

Rio Tinto has a trailing twelve months price to earnings ratio of 8.22. Meaning, the purchaser of the share is investing $8.22 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 24.02%.

Volume

Today’s last reported volume for Rio Tinto is 2640510 which is 18.02% below its average volume of 3221030.

Revenue Growth

Year-on-year quarterly revenue growth declined by 15.2%, now sitting on 55.55B for the twelve trailing months.

Moving Average

Rio Tinto’s worth is under its 50-day moving average of $63.28 and below its 200-day moving average of $65.75.

2. Leggett & Platt (LEG)

88% Payout Ratio

Leggett & Platt, Incorporated designs, manufactures, and markets engineered components and products worldwide. It operates through three segments: Bedding Products; Specialized Products; and Furniture, Flooring & Textile Products. The company offers steel rods, drawn wires, foam chemicals and additives, innersprings, private label finished mattresses, wire forms for mattress foundations, adjustable beds, industrial sewing and quilting machines, and mattress packaging and glue drying equipment, as well as machines to produce innersprings for industrial users of steel rods and wires, manufacturers of finished bedding, big box and e-commerce retailers, bedding brands and mattress retailers, department stores, and home improvement centers. It also provides mechanical and pneumatic lumbar support and massage systems for automotive seating; seat suspension systems, motors and actuators, and cables; titanium, nickel, and stainless-steel tubing, formed tubes, tube assemblies, and flexible joint components for fluid conveyance systems; and engineered hydraulic cylinders to automobile OEMs and suppliers, aerospace OEMs and suppliers, and mobile equipment OEMs. In addition, the company offers steel mechanisms and motion hardware; springs and seat suspensions; components and private label finished goods for soft seating; bases, columns, back rests, casters, and frames for office chairs; control devices for chairs; and carpet cushion and hard surface flooring underlayment, structural fabrics, and geo components to manufacturers of upholstered and office furniture, flooring retailers and distributors, contractors, landscapers, road construction companies, retailers, government agencies, and mattress and furniture producers, as well as manufacturers of packaging, filtration, and draperies. The company was founded in 1883 and is based in Carthage, Missouri.

Earnings Per Share

As for profitability, Leggett & Platt has a trailing twelve months EPS of $1.98.

PE Ratio

Leggett & Platt has a trailing twelve months price to earnings ratio of 14.72. Meaning, the purchaser of the share is investing $14.72 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 16.35%.

Earnings Before Interest, Taxes, Depreciation, and Amortization

Leggett & Platt’s EBITDA is 46.14.

Sales Growth

Leggett & Platt’s sales growth is negative 6.8% for the ongoing quarter and 3.4% for the next.

Moving Average

Leggett & Platt’s worth is under its 50-day moving average of $31.45 and way under its 200-day moving average of $33.07.

3. Abbott Laboratories (ABT)

58.36% Payout Ratio

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. The Diagnostic Products segment offers laboratory systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, as well as detect and measure infectious agents; point of care systems; cartridges for testing blood; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for use in laboratories. The Nutritional Products segment provides pediatric and adult nutritional products. The Medical Devices segment offers rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; and diabetes care products, as well as neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois.

Earnings Per Share

As for profitability, Abbott Laboratories has a trailing twelve months EPS of $3.29.

PE Ratio

Abbott Laboratories has a trailing twelve months price to earnings ratio of 32.51. Meaning, the purchaser of the share is investing $32.51 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 15.93%.

Moving Average

Abbott Laboratories’s worth is under its 50-day moving average of $107.15 and above its 200-day moving average of $104.97.

4. Robert Half International (RHI)

31.33% Payout Ratio

Robert Half International Inc. provides talent solutions and business consulting service in North America, South America, Europe, Asia, and Australia. The company operates through three segments: Contract Talent Solutions, Permanent Placement Talent Solutions, and Protiviti. The Contract Talent Solutions segment provides contract engagement professionals in the fields of finance and accounting, technology, marketing and creative, legal and administrative, and customer support. This segment markets its services to clients and employment candidates through both national and local advertising activities, including radio, digital advertising, job boards, alliance partners, and events. The Permanent Placement Talent Solutions segment engages in the placement of full-time accounting, finance, and tax and accounting operations personnel. The Protiviti segment offers consulting services in the areas of internal audit, technology consulting, risk and compliance consulting, digital transformation, legal consulting, and business performance improvement. The company offers it services under the Robert Half brand name. Robert Half International Inc. was founded in 1948 and is headquartered in Menlo Park, California.

Earnings Per Share

As for profitability, Robert Half International has a trailing twelve months EPS of $5.65.

PE Ratio

Robert Half International has a trailing twelve months price to earnings ratio of 12.72. Meaning, the purchaser of the share is investing $12.72 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 40.09%.

Earnings Before Interest, Taxes, Depreciation, and Amortization

Robert Half International’s EBITDA is 1.04.

Leave a Reply

Your email address will not be published. Required fields are marked *